HERC2 is an E3 ligase that targets BRCA1 for degradation.

Cancer Research
Wenwen WuTomohiko Ohta

Abstract

The breast cancer suppressor BRCA1 forms a stable heterodimeric E3 ubiquitin ligase with BARD1. Each protein controls the abundance and stability of the other, and loss of the interaction leads to BRCA1 degradation. Here, we show that HERC2, a protein recently implicated in DNA damage repair, targets BARD1-uncoupled BRCA1 for degradation. HERC2 shuttles between the nucleus and the cytoplasm. Its COOH-terminal HECT-containing domain interacts with an NH(2)-terminal degron domain in BRCA1. HERC2 ubiquitinates BRCA1; this reaction depends on Cys(4762) of HERC2, the catalytic ubiquitin binding site, and the degron of BRCA1. The HERC2-BRCA1 interaction is maximal during the S phase of the cell cycle and rapidly diminishes as cells enter G(2)-M, inversely correlated with the steady-state level of BRCA1. Significantly, HERC2 depletion antagonizes the effects of BARD1 depletion by restoring BRCA1 expression and G(2)-M checkpoint activity. Conversely, BARD1 protects BRCA1 from HERC2-mediated ubiquitination. Collectively, our findings identify a function for HERC2 in regulating BRCA1 stability in opposition to BARD1. The HERC2 expression in breast epithelial cells and breast carcinomas suggests that this mechanism may play a role in brea...Continue Reading

References

Aug 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·M F LyonM H Brilliant
Jul 3, 1995·Proceedings of the National Academy of Sciences of the United States of America·E M RinchikM A Handel
Jul 8, 1997·Proceedings of the National Academy of Sciences of the United States of America·H Ruffner, I M Verma
Oct 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·Y JinR Baer
Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·A L LehmanM H Brilliant
Mar 30, 2001·The Journal of Biological Chemistry·R HashizumeT Ohta
Oct 11, 2001·Proceedings of the National Academy of Sciences of the United States of America·V JoukovD M Livingston
Feb 8, 2002·Cell·Ashok R Venkitaraman
Nov 13, 2002·The Journal of Biological Chemistry·Shinya Okada, Toru Ouchi
May 7, 2003·Proceedings of the National Academy of Sciences of the United States of America·Peter S BrzovicRachel Klevit
May 29, 2004·The Journal of Biological Chemistry·Atish D ChoudhuryRichard Baer
Jun 9, 2004·The Journal of Biological Chemistry·Ko SatoTomohiko Ohta
Jun 22, 2005·Cellular and Molecular Life Sciences : CMLS·F R Garcia-Gonzalo, J L Rosa
Aug 19, 2005·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Beric R Henderson
Sep 26, 2006·Oncogene·N C Turner, J S Reis-Filho
Feb 7, 2007·Cancer Research·Wenwen WuTomohiko Ohta
May 26, 2007·Science·Bijan SobhianRoger A Greenberg
Jan 9, 2008·Cell Division·Wenwen WuTomohiko Ohta
Dec 22, 2009·Nature Cell Biology·Simon Bekker-JensenNiels Mailand
Mar 23, 2010·Proceedings of the National Academy of Sciences of the United States of America·Tae-Hong KangAziz Sancar

❮ Previous
Next ❯

Citations

Aug 24, 2011·Nature Reviews. Molecular Cell Biology·Allan M WeissmanAaron Ciechanover
Apr 16, 2011·The Journal of Biological Chemistry·Simone KühnleMartin Scheffner
Oct 23, 2012·The Journal of Biological Chemistry·Yunzhe LuYanfen Hu
Jan 21, 2012·Molecular & Cellular Proteomics : MCP·Abdallah K Al-HakimLaurence Pelletier
Dec 27, 2012·Nucleic Acids Research·Chao LiuXiaochun Yu
Apr 7, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Liesel M FitzGeraldJanet L Stanford
Aug 23, 2011·Cancer Cell International·Johanne I WeberpalsJim Dimitroulakos
Mar 1, 2012·Cell & Bioscience·Bin Wang
Oct 23, 2010·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Apichart AtipairinAdisorn Ratanaphan
May 17, 2011·FEBS Letters·Tomohiko OhtaWenwen Wu
Jun 15, 2011·FEBS Letters·Simon Bekker-Jensen, Niels Mailand
Jan 8, 2016·The International Journal of Biochemistry & Cell Biology·Irmgard Irminger-FingerMaxim Pilyugin
Jan 24, 2016·Cellular and Molecular Life Sciences : CMLS·Susana Sánchez-TenaJose Luis Rosa
Dec 6, 2014·Journal of Proteome Research·Jeffrey T GalliganPeter M Howley
Jul 28, 2011·International Journal of Cancer. Journal International Du Cancer·Vanessa M YuLouis Dubeau
Apr 3, 2013·Biochimica Et Biophysica Acta·Martin Scheffner, Sharad Kumar
Jan 30, 2014·Biochemical and Biophysical Research Communications·Xiaozhen WangGenze Shao
Dec 18, 2013·Biochemical and Biophysical Research Communications·Xiaozhen WangGenze Shao
Apr 3, 2015·Open Biology·Jessica S Brown, Stephen P Jackson
Oct 31, 2014·Nucleic Acids Research·Jian YuanZhenkun Lou
Oct 19, 2014·Nucleic Acids Research·Min ZhuXingzhi Xu
Oct 21, 2016·European Journal of Human Genetics : EJHG·Fanny Morice-PicardBenoit Arveiler
Dec 22, 2017·Journal of Cellular Biochemistry·Danjie ZhuFabo Feng
Oct 19, 2017·Cancer Metastasis Reviews·Dong WangWenyi Wei
Sep 5, 2018·Journal of Biomedical Science·Shih-Han KaoKou-Juey Wu
Apr 12, 2014·The Journal of Biological Chemistry·Monica Cubillos-RojasJose Luis Rosa
May 24, 2014·The Journal of Biological Chemistry·Nickie C ChanDavid C Chan
Oct 31, 2019·Molecular Oncology·Jesús García-CanoJose Luis Rosa
Oct 14, 2015·Oncotarget·Jung-Lye KimEun-Kyoung Breuer
Aug 21, 2019·Cell Death & Disease·Min LiYuehong Yang
Apr 30, 2014·The Journal of Biological Chemistry·Toshiro MoroishiKeiichi I Nakayama

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.